Pursuit Vascular, Inc., a private company with headquarters in Minneapolis, MN, is focused on developing innovative catheter infection reduction technologies.
Catheter Infections - A Deadly and Costly Problem
The Centers for Disease Control has identified catheter-related blood stream infections (CRBSI) as one of its seven major healthcare challenges; with mortality rates up to 25% and economic costs in the billions of dollars. In the US alone, nearly 500,000 new cases of CRBSI are reported each year, with costs exceeding $3 billion. The need for improvement is compelling and urgent.
ClearGuard™ - A Promising Solution
Pursuit Vascular is developing a family of innovative single-use products that may protect patients from life-threatening infections and may provide substantial savings to the global healthcare system.
